Following Sony’s announcement that it will not support PlayStation discs starting in 2028 and conjecture that the PS6 won’t have a disc drive, it’s now been reported that Microsoft’s next-gen Xbox, ...

This week’s newsletter looks at whether the DISC assessment is still relevant today. Plus, a deep dive into the policy change ...

Disc Soft Limited, the maker of DAEMON Tools Lite, confirmed that the software had been trojanized in a supply chain attack and released a new, malware-free version. "Within less than 12 hours of ...

Volatile relationships, reckless impulsivity and an unstable identity are hallmarks of this misunderstood mental health condition. Credit...Vanessa Saba Supported by By Christina Caron On the surface, ...

The advertiser paid a fee to promote this sponsored article and may have influenced or authored the content. The views expressed in this article are those of the advertiser and do not necessarily ...

Personality tests are widely used in workplaces to shape recruitment, leadership training and team building. But what if artificial intelligence could make them faster, smarter and more accurate? New ...

Summary: The traditional DISC assessment—a staple of workplace recruitment and team building—just got a high-tech makeover. New research demonstrates that machine learning can replicate DISC results ...

Personality tests are widely used in workplaces to shape recruitment, leadership training and team building. But what if artificial intelligence could make them faster, smarter and more accurate? New ...

You’ve probably taken a personality test at some point in your life. Maybe it was a workplace assessment, an online quiz, or a well-known framework like the Myers-Briggs Type Indicator. The results ...

Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Serrano is a contributor for TIME. Personalized Content Follow this author ...

Disc Medicine is laying off a fifth of its workforce as the biotech reels from the FDA’s rejection of its rare blood disease candidate. Last month, the agency knocked back an approval application for ...